99% Strongest Nootropic Compound 7p CAS Number 1890208-58-8 Improves Mood

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: top quality
• Suitable for: Elderly, Adult
• State: Solid
• Purity: >99%
• CAS No.: 1890208-58-8
• Molecular Formula: N/a
• Molecular Weight: N/a
• Appearance: White Powder
• Grade Standard: Medicine Grade
• MOQ: 10g
• COA: Pls Contact Senwayer Freely
• Storge: 2-8 Degree
• Exp.: 24 Months
• Transport Package: 1kg/Bag, 25kg/Drum
• Specification: MOQ: 100g
• Trademark: senwayer
• Origin: China
• HS Code: 2601111000
• Production Capacity: 50kgs Per Month

Product Description

Nootropics API Compound 7p Powder CAS 1890208-58-8

Product Introduction

Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor
antagonist/synthase inhibitors . In fact compound 7p shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1).Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.
 

Function

Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.here we report phenotypic cell-based screen of chemical libraries and structure-activity-guided optimization that resulted in the identification of compound 7p which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina. in an animal model of optic nerve injury, compound 7p was shown to induce growth of gap-43 positive axons, indicating that the in vitro neurite outgrowth activity of compound 7p translates into stimulation of axon regeneration in vivo.further optimization of compound 7p and elucidation of the mechanisms by which it elicits axon regeneration in vivo will provide a rational basis for future efforts to enhance treatment strategies.
 

Other products
 

Beta-Alanine	107-95-9
Creatine monohydrate	6020-87-7
N,N-dimethylphenylethylamine citrate	Eria Jarensis Extract
L-Glutamine	56-85-9
L Arginine	74-79-3
L-leucine	61-90-5
L-Theanine	3081-61-6
l-citrulline malate	54940-97-5
L-Cysteine	52-90-4
N-Acetyl-L-Cysteine	616-91-1
L-Tryptophan	73-22-3
L-Serine	56-45-1
creatine hcl	17050-09-8
agmatine sulfate	2482-00-0
n acetyl l tyrosine	537-55-3